Dna X (SONM) Inventory (2018 - 2025)

Dna X (SONM) has 8 years of Inventory data on file, last reported at $11.0 million in Q3 2025.

• Quarterly Inventory fell 11.22% year-over-year to $11.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $11.0 million (down 11.22% YoY) and the FY2024 annual result came in at $10.6 million, up 62.97% from the prior year.
• Inventory grew to $11.0 million in Q3 2025, from $9.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $12.4 million in Q3 2024 to a low of $185000.0 in Q4 2021.
• A 5-year average of $6.8 million and a median of $6.5 million in 2023 frame the typical range for Inventory.
• Annual changes were most pronounced in 2021 — Inventory plunged 98.37% — and 2023, when it soared 3276.68%.
• Tracing SONM's Inventory over 5 years: stood at $185000.0 in 2021, then climbed by 4.32% to $193000.0 in 2022, then soared by 3276.68% to $6.5 million in 2023, then surged by 62.97% to $10.6 million in 2024, then climbed by 3.44% to $11.0 million in 2025.
• The last three Inventory figures came in at $11.0 million (Q3 2025), $9.9 million (Q2 2025), and $8.6 million (Q1 2025), per Business Quant data.